Fasciola hepatica vaccine: We may not be there yet but we're on the right road
- Publication Type:
- Journal Article
- Veterinary Parasitology, 2015, 208 (1-2), pp. 101 - 111
- Issue Date:
Files in This Item:
|\\utsfs.adsroot.uts.edu.au\homes\staff\990777\Desktop\1-s2.0-S0304401715000084-main.pdf||Accepted Manuscript Version||667.16 kB|
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
© 2015 The Authors. Major advances have been made in identifying potential vaccine molecules for the control of fasciolosis in livestock but we have yet to reach the level of efficacy required for commercialisation. The pathogenesis of fasciolosis is associated with liver damage that is inflicted by migrating and feeding immature flukes as well as host inflammatory immune responses to parasite-secreted molecules and tissue damage alarm signals. Immune suppression/modulation by the parasites prevents the development of protective immune responses as evidenced by the lack of immunity observed in naturally and experimentally infected animals. In our opinion, future efforts need to focus on understanding how parasites invade and penetrate the tissues of their hosts and how they potentiate and control the ensuing immune responses, particularly in the first days of infection. Emerging 'omics' data employed in an unbiased approach are helping us understand liver fluke biology and, in parallel with new immunological data, to identify molecules that are essential to parasite development and accessible to vaccine-induced immune responses.
Please use this identifier to cite or link to this item: